Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male healthy participants

Overview of attention for article published in British Journal of Clinical Pharmacology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 11 X users

wikipedia: 1 Wikipedia page
reddit: 5 Redditors

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 6 Reddit threads by 5 users.

https://pubmed.ncbi.nlm.nih.gov/37452623/

User theburgernerd1, in the spinalfusion subreddit, 11 Oct 2024

https://pubmed.ncbi.nlm.nih.gov/37452623/

Hi ok Pepper here's the article I read...

User theburgernerd1, in the spinalfusion subreddit, 11 Oct 2024

Hi ok Pepper here's the article I read https://pubmed.ncbi.nlm.nih.gov/37452623/

https://pubmed.ncbi.nlm.nih.gov/37452623/

User Front_Inflation_6521, in the NervGen_NerveRepair subreddit, 10 Aug 2024

https://pubmed.ncbi.nlm.nih.gov/37452623/

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants

User KaiserSushi, in the Spinal Cord Injuries subreddit, 10 Aug 2023

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity, including 2 additional Reddit threads.